Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
129,668,560
-
Total 13F shares
-
108,913,619
-
Share change
-
-7,714,087
-
Total reported value
-
$937,694,058
-
Put/Call ratio
-
20%
-
Price per share
-
$8.61
-
Number of holders
-
228
-
Value change
-
-$63,533,202
-
Number of buys
-
102
-
Number of sells
-
106
Institutional Holders of NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) as of Q3 2022
As of 30 Sep 2022,
NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) was held by
228 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
108,913,619 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, BROWN ADVISORY INC, JANUS HENDERSON GROUP PLC, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, First Light Asset Management, LLC, GOLDMAN SACHS GROUP INC, T. Rowe Price Investment Management, Inc., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
230
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.